Federated Hermes’s Achillion Pharmaceuticals ACHN Stock Holding History

Federated Hermes’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,668	Closed	-$58K	–	2436
2019 Q4	$58K	Sell	9,668 -4,591	-32%	-$26.6K	﹤0.01%	1726
2019 Q3	$51K	Sell	14,259 -4,460	-24%	-$17.2K	﹤0.01%	1726
2019 Q2	$50K	Buy	+18,719	New	+$55.3K	﹤0.01%	1679
2018 Q1	–	Sell	-5,819	Closed	-$17K	–	2273
2017 Q4	$17K	Buy	+5,819	New	+$21.1K	﹤0.01%	1804
2015 Q1	–	Sell	-40,764	Closed	-$499K	–	2091
2014 Q4	$499K	Buy	40,764 +29,896	+275%	+$365K	﹤0.01%	1354
2014 Q3	$108K	Buy	+10,868	New	+$101K	﹤0.01%	1571
2013 Q3	–	Sell	-730,241	Closed	-$5.97M	–	1796
2013 Q2	$5.97M	Buy	+730,241	New	+$5.57M	0.02%	524

Federated Hermes's ACHN Position: Q1 2020 in Review

Federated Hermes sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 9,668 shares — an estimated $58K sold.

Federated Hermes first reported a position in ACHN in Q2 2013 and held it in 7 quarters. The position peaked at $5.97M in Q2 2013. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Federated Hermes reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Federated Hermes sold 9,668 Achillion Pharmaceuticals shares in Q1 2020, an estimated $58K.
Federated Hermes first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 7 quarters.
Federated Hermes's Achillion Pharmaceuticals position peaked at $5.97M in Q2 2013.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Federated Hermes's 13F filing for Q1 2020, filed 13 May 2020.